Dear Sir, I read with interest the article by E. Schloericke et al. [1] , entitled "Surgical management of complicated rectovaginal fistulas and the role of omentoplasty" published in Techniques in Coloproctology, in which the authors reported their treatment of rectovaginal fistulas in 58 patients, 19 of whom had a history of cancer with a primary localization in the pelvis. There are important considerations to make before transposing the omentum to the pelvis in patients with cancer. As reported in many studies [2] , peritoneal carcinomatosis is actually considered a locoregional disease, in which the omentum plays a fundamental role. As reported by Liu [3] , invasive peritoneal-exfoliated cancer cells preferentially select the omentum as a predominant target site for cancer cell colonization. Moreover, although the mechanisms underlying peritoneal dissemination have not yet been elucidated, milky spots provide suitable 'soil' for cancer cells to implant [4] . Milky spots, described in 1863 by Recklinghausen as white spots in the omentum of young rabbits [5] , and in 1921 by Seifert in the human omentum [6] , are lymphatic orifices on the surface of the peritoneum that can be considered as open gates for peritoneal-free cancer cells to migrate into the submesothelial space (3). In the light of these considerations, I think that the transposition of the omentum to the pelvis may potentially increase the incidence of cancer recurrence in patients with a history of cancer, especially cancer of gastrointestinal and ovarian origin, and cannot be recommended in the absence of randomized studies that analyze their oncological outcome.
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